LupusTrials.org

JBT-101 in Systemic Lupus Erythematosus (SLE)

Posted on

The objective of this study is to evaluate the efficacy, safety, and tolerability of JBT-101 (also known as lenabasum) in systemic lupus erythematosus (SLE).

To Learn More Contact
Visit ClinicalTrials.gov to search for sites near you and reach out to Contact listed.
ClinicalTrials.gov identifier: NCT03093402

Sign up for our Newsletter

Use this tool to search all lupus trials and create a personalized list of studies by the type of lupus you have and where you live.

Sign up